Gout drug may halt dangerous seizure clusters in epilepsy patients
NCT ID NCT07318870
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether probenecid, a medicine used for gout, can stop cluster seizures in people with focal epilepsy. Participants are patients aged 6 to 50 who are in the hospital for presurgical monitoring and have their usual seizure medications paused to trigger seizures. The goal is to see if a single dose of probenecid prevents further seizures for 12 hours, using video-EEG to track results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••